Findings: a heart-healthy lifestyle reduces DM risk; 1 egg a day may protect against T2DM; and a new genetic risk score may improve DM diagnosis.
Survodutide: Novel GCGR/GLP-1RA Shows Promise in Obesity, MASH Treatment
EASD 2024: New data shows survodutide may be beneficial for persons with obesity and MASH.
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
FDA Expands Omnipod 5 AID System Label to Treat T2D: Daily Dose
Your daily dose of the clinical news you may have missed.
Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.
Tirzepatide Reduces Risk for Progression from Prediabetes to T2D: Daily Dose
PTSD and Risk of Poor T2D Outcomes in Veterans: Daily Dose